Cambridge, MA March 10, 2009 Phylonix Pharmaceuticals, Inc., the leading contract research organization for preclinical testing in zebrafish, will present data about the company's in vivo zebrafish-based assays at the 48th Society of Toxicology (SOT) Annual Meeting being held March 15-19 at the Baltimore Convention Center in Baltimore, Maryland. A podium presentation will be presented at SOT on Tuesday, March 17 and two posters will be presented on Monday, March 16 and Tuesday, March 17, respectively.
"Assessment of Ototoxicity and Otoprotection in a Zebrafish Hair Cell Model"
Tuesday, March 17, 10:36 am - 10:59 am, Room 308
"Assessment of Drug Induced Cardiotoxicity in Transparent Zebrafish"
Monday, March 16, 1:00 pm - 4:30 pm
390 Poster / Board 207
"Zebrafish: A Predictive Model for Assessing P-Glycoprotein Inhibitors"
Tuesday, March 17, 9:00 am-12:30 pm
983 Poster / Board 534
The company is exhibiting at ToxExpo in Booth 2950 from Monday, March 16 through Wednesday, March 18; and is also sponsoring a lunch hour workshop, "Zebrafish: A Predictive Model for Assessing Safety and Toxicity," on Monday, March 16 from 12:15 pm-1:15 pm. Space is limited and reservations are required. Please contact Kristine.firstname.lastname@example.org or 617-441-6700 x312 to reserve your seat or for more information.
|Contact: Edward O'Lear|